First Time Loading...

Twist Bioscience Corp
NASDAQ:TWST

Watchlist Manager
Twist Bioscience Corp Logo
Twist Bioscience Corp
NASDAQ:TWST
Watchlist
Price: 41.21 USD 28.74% Market Closed
Updated: May 5, 2024

Twist Bioscience Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Twist Bioscience Corp
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Twist Bioscience Corp
NASDAQ:TWST
Revenue
$262.4m
CAGR 3-Years
37%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Twist Bioscience Corp
Revenue Breakdown

Breakdown by Geography
Twist Bioscience Corp

Total Revenue: 245.1m USD
100%
Americas: 151.3m USD
61.7%
EMEA: 71.4m USD
29.1%
Asia Pacific: 22.5m USD
9.2%

Breakdown by Segments
Twist Bioscience Corp

Total Revenue: 245.1m USD
100%
Ngs Tools: 123.7m USD
50.5%
Synthetic Genes: 73.5m USD
30%
Antibody Discovery: 23.2m USD
9.5%
Oligo Pools: 14.5m USD
5.9%
Dna And Biopharma Libraries: 10.2m USD
4.2%
Show More
Show Less

See Also

What is Twist Bioscience Corp's Revenue?
Revenue
262.4m USD

Based on the financial report for Dec 31, 2023, Twist Bioscience Corp's Revenue amounts to 262.4m USD.

What is Twist Bioscience Corp's Revenue growth rate?
Revenue CAGR 5Y
52%

Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Twist Bioscience Corp have been 37% over the past three years , 52% over the past five years .